The deal comes as Chinese novel drug makers are having more say in how their new medicines are developed with global partners ...
Replacing animal testing with alternate methodologies in preclinical drug trials holds potential for the development of ...
A team of biochemists at the University of California, Santa Cruz, has developed a faster way to identify molecules in the ...
AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.
An extraction-free kit enables gene expression analysis directly from hepatocyte lysates, delivering results in 75 minutes with sensitivity comparable to RNA purification.
Scholars warn that replacing animal testing too quickly may threaten drug safety. As the FDA promotes AI and organoids, ...
Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "AI in Drug Discovery Market, till 2040: Distribution by Drug Discovery Steps, Therapeutic Area, and Key Geographical Regions: Industry Trends and Global ...
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development process for industry and patients. Our two companies are applying AI in ...
Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
In the pursuit of solutions to complex global challenges including disease, energy demands, and climate change, scientific ...
The EMA and FDA have published a set of 10 'common principles' that should be taken into account when using AI in the development of medicines. The list has emerged as the adoption of AI among ...
Automation and AI are revolutionizing the pharmaceutical industry, optimizing technical development and enabling faster, more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results